Overview

Shanghai Jinwei Biotechnology Co., Ltd. (Jinwei) is a biotechnology company dedicated to pursue innovative technology to develop cures for people with serious and life-threatening diseases. Jinwei has obtained exclusive licenses of multiple patents and other intellectual property owned by the Pasteur Institute and Theravectys for development, manufacture and commercialization of therapeutic products based on lentiviral vectors. The GMP production facility located in Shanghai is dedicated to provide safe and reliable viral vector-based products, helping to translate early stage research into commercially viable therapies.